
Rosiglitazone prevents the memory deficits induced by amyloid-beta oligomers via inhibition of inflammatory responses
Keywords: تقویت درازمدت; Amyloid-beta 42 oligomers; Rosiglitazone; Alzheimer's disease; Long-term potentiation; Inflammatory cytokines